Harlequin is a CBD-rich strain whose popularity predated the recent wave of non-psychoactive medical CBD strains like Charlotte’s Web. Harlequin is the sativa-dominant product of several different landrace strains: 1970s favorite Colombian Gold, Thai and Swiss sativa landraces, and a Nepali indica variety. These patchwork genetics may account for the strain’s name — “harlequin” originally referred to the brightly-patterned costumes of traditional Italian clowns of the same name. Harlequin is approximately 75% sativa, although it lacks the characteristically strong cerebral sativa high due to the mitigating presence of CBD. The standard ratio of CBD to THC in Harlequin is 5:2. Cannabis lab Analytics 360 has measured samples of this strain at between 4% to 10% THC and 6% to 15% CBD. Harlequin has won multiple Cannabis Cup awards for its CBD content in both bud and concentrate form.